Richard H. Scheller
Richard H. Scheller holds the position of Chairman of DiCE Therapeutics, Inc, Chairman of DICE Molecules SV, Inc. (a subsidiary of DiCE Therapeutics, Inc) and Director, Chairman-Research & Development at BridgeBio Pharma, Inc., Director, Chairman-Research & Development at BridgeBio Pharma LLC (a subsidiary of BridgeBio Pharma, Inc.). Dr. Scheller is also Member of National Academy of Sciences, Member of American Academy of Arts & Sciences and Member of National Academy of Medicine (United States) and on the board of 8 other companies.
Dr. Scheller previously was Head-Genentech Research & Early Development at Roche Holding AG and Executive VP, Head-Research & Early Development at Genentech, Inc. (a subsidiary of Roche Holding AG), Director & Chief Scientific Officer at Medrio, Inc. and Professor at Stanford University.
He received a doctorate from California Institute of Technology, a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Wisconsin.
|11/11/2022||18,421||Disposition at $3.24 per share.||59,685|
|09/06/2022||14,633||Award at $0 per share.||0|
|08/25/2022||57,755||Award at $0 per share.||0|
|09/14/2021||18,421||Award at $0 per share.||0|